The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
G | Genito urinary system and sex hormones | |
2
|
G01 | Gynecological antiinfectives and antiseptics | |
3
|
G01A | ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS | |
4
|
G01AF | Imidazole derivatives | |
5
|
G01AF02 | Clotrimazole |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Code | Route | Amount | Notes |
|---|---|---|---|
| VAGIN | Vaginal | 0.1 g |
| Active Ingredient |
|---|
|
Clotrimazole acts against fungi by inhibiting ergosterol synthesis. Inhibition of ergosterol synthesis leads to structural and functional impairment of the fungal cytoplasmic membrane. Clotrimazole has a broad antimycotic spectrum of action in vitro and in vivo, which includes dermatophytes, yeasts, moulds, etc. |
| Document | Type | Information Source | |
|---|---|---|---|
| CANESTEN THRUSH INTERNAL CREAM 10% w/w Vaginal cream | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| CLOTRIMADERM Vaginal cream | MPI, CA: SPM | Health Products and Food Branch (CA) | |
| MYCORIL Vaginal tablet | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| WARIMAZOL VAG 1% Vaginal cream | MPI, EU: SmPC | Υπουργείο Υγείας (CY) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.